Edema News and Research

RSS
Edema means swelling caused by fluid in your body's tissues. It usually occurs in the feet, ankles and legs, but it can involve your entire body.
C1-INH concentrate, an effective therapy to treat acute swelling attacks for HAE

C1-INH concentrate, an effective therapy to treat acute swelling attacks for HAE

ThromboGenics issues business update for the third-quarter of 2009

ThromboGenics issues business update for the third-quarter of 2009

Interim data from Schering-Plough's narlaprevir Phase IIa study

Interim data from Schering-Plough's narlaprevir Phase IIa study

Study of combination therapy versus monotherapy for pulmonary arterial hypertension

Study of combination therapy versus monotherapy for pulmonary arterial hypertension

Multicenter study finds AMD patients can benefit from cataract surgery

Multicenter study finds AMD patients can benefit from cataract surgery

Schering-Plough receives FDA complete response letter regarding PEGINTRON

Schering-Plough receives FDA complete response letter regarding PEGINTRON

iCo Therapeutics announces $4,000,000 brokered private placement

iCo Therapeutics announces $4,000,000 brokered private placement

King Pharmaceuticals receives exclusive rights to market and sell CYANOKIT

King Pharmaceuticals receives exclusive rights to market and sell CYANOKIT

Isotechnika Pharma reports voclosporin Phase 2/3 clinical trial results at the AAO meeting

Isotechnika Pharma reports voclosporin Phase 2/3 clinical trial results at the AAO meeting

Hyperion Therapeutics enrolls first patient in HPN-100 phase III clinical trial for urea cycle disorders

Hyperion Therapeutics enrolls first patient in HPN-100 phase III clinical trial for urea cycle disorders

Quark Pharmaceuticals receives a Japanese patent for its hypoxia regulated genes

Quark Pharmaceuticals receives a Japanese patent for its hypoxia regulated genes

LX211 may become the first approved oral treatment for modifying the course of uveitis

LX211 may become the first approved oral treatment for modifying the course of uveitis

Millennium commences Vc-R-CHOP Phase II trial for diffuse large B-cell lymphoma

Millennium commences Vc-R-CHOP Phase II trial for diffuse large B-cell lymphoma

FDA grants Fast Track designation for MacuSight's Perceiva

FDA grants Fast Track designation for MacuSight's Perceiva

APP Pharmaceuticals to launch Chlorothiazide Sodium for Injection

APP Pharmaceuticals to launch Chlorothiazide Sodium for Injection

Novartis' Tasigna capsules meets primary endpoint in comparison trial with Gleevec

Novartis' Tasigna capsules meets primary endpoint in comparison trial with Gleevec

Boehringer Ingelheim Pharmaceuticals receives NDA approval from FDA for its Micardis Tablets 80 mg

Boehringer Ingelheim Pharmaceuticals receives NDA approval from FDA for its Micardis Tablets 80 mg

Schering-Plough to present data on boceprevir at the AASLD 2009 Annual Meeting

Schering-Plough to present data on boceprevir at the AASLD 2009 Annual Meeting

FDA grants marketing approval for Elitek

FDA grants marketing approval for Elitek

pSivida achieves milestone in Phase III Iluvien trial, last patient completes two-year follow up visit

pSivida achieves milestone in Phase III Iluvien trial, last patient completes two-year follow up visit